Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,026 GBX | +3.53% | +4.47% | -38.92% |
05-03 | Jefferies cuts AJ Bell; Deutsche likes ConvaTec | AN |
05-01 | EXECUTIVE CHANGES: New chairs for CVS Group, LSL Property and Videndum | AN |
Sales 2024 * | 672M 851M 67.23B | Sales 2025 * | 720M 911M 71.99B | Capitalization | 711M 900M 71.08B |
---|---|---|---|---|---|
Net income 2024 * | 43M 54.44M 4.3B | Net income 2025 * | 52M 65.83M 5.2B | EV / Sales 2024 * | 1.38 x |
Net Debt 2024 * | 219M 277M 21.9B | Net Debt 2025 * | 174M 220M 17.36B | EV / Sales 2025 * | 1.23 x |
P/E ratio 2024 * |
17.1
x | P/E ratio 2025 * |
13.6
x | Employees | 9,100 |
Yield 2024 * |
0.8% | Yield 2025 * |
0.86% | Free-Float | 98.44% |
Latest transcript on CVS Group plc
1 day | +3.73% | ||
1 week | +4.47% | ||
Current month | +5.01% | ||
1 month | +11.50% | ||
3 months | -39.10% | ||
6 months | -34.36% | ||
Current year | -38.92% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Fairman
CEO | Chief Executive Officer | 57 | 31/07/18 |
Robin Alfonso
DFI | Director of Finance/CFO | 45 | 05/11/19 |
Richard Killen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Deborah Kemp
BRD | Director/Board Member | 62 | 01/01/18 |
David Wilton
CHM | Chairman | 61 | 23/09/21 |
Richard Fairman
CEO | Chief Executive Officer | 57 | 31/07/18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.84% | 1 M€ | -.--% | ||
0.04% | 746 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
15/05/24 | 1,026 | +3.53% | 1 141 365 |
14/05/24 | 991 | +3.77% | 424,623 |
13/05/24 | 955 | -2.85% | 552,899 |
10/05/24 | 983 | +0.51% | 191,667 |
09/05/24 | 978 | -0.61% | 209,318 |
Delayed Quote London S.E., May 15, 2024 at 04:07 pm
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CVSG Stock